The CDP-choline pathway is the predominate route to phosphatidylcholine (PtdCho) in most tissues (18, 37) . The choline cytidylyltransferase ␣ (CCT␣) protein is the major isoform that governs this pathway, while CCT␤2 and CCT␤3 mRNAs are usually expressed at 10-to 30-fold-lower levels (19) . Loss of CCT␣ expression is lethal at day 3.5 of embryonic development (E3.5), and embryos fail to form blastocysts (40) . These data illustrate a strict dependence on CCT␣ expression early in embryogenesis beyond the first few rounds of cell division following fertilization, which are otherwise supported by maternal CCT␤ expression in the unfertilized ova (19) . This early embryonic lethality reflects culture systems where cell death occurs when the CCT step is blocked (1, 11, 12, 29) . On the other hand, selective deletion of the CCT␣ gene (Pcyt1a) does not inhibit the growth or differentiation of macrophages in vivo, although the viability of the CCT␣-deficient macrophages is compromised when the cells are loaded with free cholesterol (45) . The deletion of CCT␣ in hepatocytes also does not impair their development or differentiation, but they are larger, and secretion of high-density lipoprotein and very low density lipoprotein is impaired (21) . The apparently normal development of these tissues is somewhat surprising. It may be due to compensation by the upregulation of CCT␤ isoforms (21, 45) ; however, the inability of the hepatocytes with CCT␣ deleted to proliferate in vitro suggests that there may be an alternate source of PtdCho that is not recapitulated in culture and that makes the CCTs dispensable in differentiated tissues.
In the lung, PtdCho biosynthesis via the CDP-choline pathway is a major contributor to formation of cell membranes and specialized intracellular lamellar bodies. The lamellar bodies found in type II epithelial cells are derived from lysosomes and contain dipalmitoyl-PtdCho, the major phospholipid component of lung surfactant (30, 31, 36) . Expression of the CCT␣ isoform predominates in lung tissue, and the CCT␤ mRNAs are expressed at about a 30-fold-lower level (19, 30, 40) . There is a small, but significant, reduction in the total PtdCho content of adult lungs in Pcyt1a ϩ/Ϫ heterozygous mice, whereas the PtdCho levels in other adult tissues are comparable to those of the wild-type littermates (19) , suggesting that lung tissue may be less resilient to CCT␣ ablation than hepatocytes or macrophages. Also, the highest relative levels of CCT␣ mRNA expression occur in lung (19, 30) , and in contrast to other cell types where CCT␣ is primarily nuclear (41) , the CCT␣ protein is cytoplasmic (30) and localizes with developing lamellar bodies found in the glycogen stores of fetal lung type II cells (31) . The lamellar bodies contain surfactant proteins (31) along with disaturated PtdCho (14) and are secreted into the alveoli to enable lung expansion and air exchange (14) .
Our approach to probing the role of CCT␣ in lung biology was to derive mice with CCT␣ deficiency restricted to the lung epithelial cells. This was accomplished using a genetic system that controls Cre recombinase expression in lung epithelial progenitors using the doxycycline (Dox)-dependent human surfactant protein C (SP-C) promoter (27, 28, 43) . These studies show that CCT␣ is not required for PtdCho synthesis sup-Statistical analysis. The unpaired Student t test was used for statistical analysis, and all the data were calculated and plotted with Graphpad Prism 4 (Graphpad Software). The results are given as means Ϯ standard errors or Ϯ the standard deviation. The results are considered significant at P values of Ͻ0.05 or P values of Ͻ0.01 (see Fig. 1 to 4) .
RESULTS
Deletion of Pcyt1a in the respiratory epithelium. SP-CrtTA tg/0 /(tetO) 7 CMV-Cre tg/tg /Pcyt1a fl/fl mice were derived and mated to produce Pcyt1a ⌬/⌬ mice in which Pcyt1a was deleted by activation of Cre recombinase in respiratory epithelial cells by administration of Dox to the pregnant dams. The deletion removed exons 5 and 6, thus inactivating the catalytic function of CCT␣, and was documented by PCR analysis of lung genomic DNA with specific primers which yielded a 255-bp product (Fig. 1A) . Complete ablation of expression in whole lung was never observed because the gene remained intact in other lineages. SP-C-rtTA 0/0 /(tetO) 7 CMV-Cre tg/tg /Pcyt1a fl/fl littermate embryos were generated in each cross, along with the SP-C-rtTA tg/0 /(tetO) 7 CMV-Cre tg/tg /Pcyt1a ⌬/⌬ mice, and were used as the experimental controls. There are two genes in the CCT family, CCT␣ and CCT␤, and a second pathway for PtdCho synthesis via the N methylation of phosphatidylethanolamine (18) . Quantification of these four mRNAs in Pcyt1a ⌬/⌬ -knockout lungs showed that Pcyt1a mRNA was significantly decreased, but there was no change in expression of the genes that produced CCT␤1, CCT␤2, or phosphatidylethanolamine N-methyltransferase (Fig. 1B) .
Lung morphology and epithelial differentiation. The type II pneumocytes are cuboidal cells clustered at the junction between the alveolar ducts and the alveoli that express very high levels of surfactant protein and have large cytoplasmic lamellar bodies. Type I pneumocytes are flattened, do not express surfactant proteins, and lie in close apposition to the capillaries of the alveoli. Histological examination of control mice revealed normal lung morphology with dilated terminal lung, thin interstitial septa, and normal growth of pulmonary capillaries in close proximity to squamous type I respiratory epithelial cells (Fig. 1C ). The gas exchange surface was fully formed. Lung pathology in Pcyt1a ⌬/⌬ mice was severe, with focal or extensive atelectasis (Fig. 1C) , hyaline membrane formation, and pulmonary congestions. Neonatal Pcyt1a ⌬/⌬ mice were in respiratory distress and moribund. Dilation of the peripheral saccules was reduced, and the septa remained thickened, but the septations appeared normal, and the peripheral saccules were lined with cuboidal type II cells and squamous type I cells.
Immunohistochemistry of control and Pcyt1a ⌬/⌬ mouse lungs at birth (E19.5) confirmed a reduction of CCT␣ protein in lung epithelium, particularly in the type II epithelial cells which were heavily stained in the control lungs (Fig. 1D) . For the control mice, CCT␣ antibody primarily labeled the cytoplasms of type II cells rather than the nuclei. Lung weights in Pcyt1a ⌬/⌬ mice were similar to those of the controls, and there was no evidence of cell injury or inflammation at birth. The number of brightly stained type II cells was markedly reduced in the terminal lung saccules of all Pcyt1a ⌬/⌬ mice (Fig. 1D) (Fig. 1E) , which was consistent with the immunohistochemistry (Fig. 1D) .
Respiratory distress phenotype. Deletion of Pcyt1a in endodermal progenitor cells with Dox exposure beginning at E6.5 to E7.5 resulted in 100% neonatal mortality for the Pcyt1a ⌬/⌬ mice, while the control Pcyt1a fl/fl littermates had an almost 100% survival rate (n ϭ 12 litters). Pcyt1a ⌬/⌬ mice developed severe respiratory distress immediately after birth, became cyanotic, and died within 10 min of delivery. Dox administration beginning at either E10.5 or E12.5 and continuing until birth (E18.5 to E19.5) recapitulated the results at E6.5 with 100% neonatal death (n ϭ 19 and 11 pups, respectively) for the Pcyt1a ⌬/⌬ animals. Neonatal lungs on the day of birth were excised intact and floated in saline to determine whether the lungs were inflated. The lungs from Pcyt1a ⌬/⌬ animals sank (100%, n ϭ 18 pups), whereas the lungs from the Pcyt1a fl/fl littermates floated (100%, n ϭ 19 pups), indicating that the knockout lungs did not inflate. However, Dox administration from E16.5 to term resulted in only 10% mortality in the Pcyt1a ⌬/⌬ neonates (n ϭ 11 pups), and the excised lungs from the viable Pcyt1a ⌬/⌬ mice were inflated and had normal lung morphology, with type II pneumocytes clustered at the junction between the alveolar ducts and the alveoli (data not shown). Although toxicity from expression of the Cre-recombinase and rtTA proteins has been reported (44), we did not observe significant neonatal death related to the SP-C-rtTA heterozygous and tetO-Cre homozygous genotypes, where the Pcyt1a alleles were homozygous wild-type.
Stage-specific human SP-C promoter activation and CCT␣ deletion. Activation of the (tetO) 7 CMV promoter with 4-day Dox pulses was performed to determine when ablation of CCT␣ expression occurred during lung development. Promoter activation was expected to be maximal 48 h after starting Dox treatment and to diminish to zero 48 h after Dox removal (28) . Dox administration between E0.5 to E4.5 did not result in a significant change in the PtdCho content of late-term lungs ( Fig. 2A) , as expected, because the embryo develops independently without maternal influence until implantation at E5.5. Providing Dox between E4.5 and E8.5 would delete Pcyt1a in lung progenitor cells (28) and in the ventral foregut of the E9.5 embryo. However, activation of the SP-C promoter in endodermal progenitors prior to lung bud formation (E9.5) resulted in no significant alteration in PtdCho production ( Fig.  2A) . Between E10.5 and E14.5, the proximal-distal differenti- 
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fl/fl mice did not give rise to a phenotype, due to a lack of Cre-recombinase expression (28) . These data showed that CCT␣ deletion via Dox activation of the SP-C promoter yielded a phenotype between days 8 and 16 of embryonic development.
Lipid and protein composition of Pcyt1a ⌬/⌬ lungs. The lung phospholipid composition was examined in lungs from embryos treated with Dox between E0 and E17. There was significantly reduced PtdCho content in the late-term lungs (E17.5) from SP-CPcyt1a ⌬/⌬ mice compared to that for the Pcyt1a fl/fl littermate controls (Fig. 2B) . Neither phosphatidylethanolamine nor cholesterol was significantly decreased, but there was a significant increase in triglycerides (Fig. 2B) . The molecular species of PtdCho in Pcyt1a ⌬/⌬ lungs showed a pronounced decrease in the proportion of dipalmitoyl-PtdCho (16:0/16:0; m/z ϭ 734), suggesting a selective depletion of the C 16:0 fatty acid that was used in the formation of the surfactant (compare Fig. 2C and D) . The triglyceride fraction exhibited a corresponding increase in the proportion of species containing C 16:0 , notably in the species containing 48 and 60 carbons (compare Fig. 2G and F) . These analytic data indicated that the production of dipalmitoyl-PtdCho was selectively affected by loss of CCT␣ activity. The enrichment of the lungs with triglycerides containing palmitic acid (C 16:0 ) suggested that surfactant fatty acid synthesis continued in Pcyt1a ⌬/⌬ lungs and shunted into the triglyceride pool when PtdCho formation was blocked. These data reflect findings for cultured cells where the diversion of fatty acids to the triglyceride pool was observed when CCT␣ was inhibited (20) . 
We analyzed the bronchial-alveolar lavage (BAL) fluid from four Pcyt1a
⌬/⌬ and control mice to verify the anticipated deficiency in surfactant production (Fig. 3) . The total BAL fluid contained significantly less phospholipid per lung than that of the controls, and the fractionation of BAL into the large (LA) and small (SA) aggregate fractions showed that both were severely depleted in total phospholipid (Fig. 3A) . The protein content of BAL and its subfractions was also reduced in Pcyt1a ⌬/⌬ mice compared to that for the controls (Fig. 3B) ; however, the reduction in surfactant protein was less than the reduction in total phospholipid. This translated into a 4.7-, 2.8-, and 7.4-fold increase in the protein:phospholipid ratio in BAL, LA, and SA, respectively. These data showed that the Pcyt1a ⌬/⌬ pups had a deficiency in surfactant that was most pronounced in the phospholipid fraction.
Surfactant protein expression. By E14.5, the distal epithelial cells begin to express surfactant proteins. Between E16.5 and E17.5, the distal epithelial cells become flattened as the distal endoderm begins to form terminal sacs and the epithelia differentiate into two distinct cell types, type I and type II pneumocytes. Expression of mouse surfactant protein becomes restricted to the type II alveolar pneumocytes, which have large cytoplasmic secretory vacuoles, known as lamellar bodies, containing whorls of surfactant protein and lipid (see Fig. 5B ). Deletion of CCT␣ expression from the type II cell population did not reduce SP-B or SP-C transcript levels, and differences in the levels of SP-A or SP-D mRNAs were not significant (Fig.  4A) . In contrast, the Pcyt1a ⌬/⌬ -knockout lungs had significantly reduced amounts of SP-A, SP-C, and SP-D proteins and elevated SP-B protein content (Fig. 4B) . These data show that CCT␣ depletion did not blunt surfactant protein gene expression but altered their translation or turnover.
Type II cell ultrastructure. The selective deletion of CCT␣ expression in lung epithelia resulted in marked differences in the ultrastructure of type II cells at birth (Fig. 5) . In the control lungs, the type II alveolar epithelial cells contained numerous forming and mature lamellar bodies and an extensive elaboration of apical microvilli ( Fig. 5A and B) . The peripheral saccules were well dilated, with a thin alveolar wall with squamous-like type I cells and cuboidal type II cells lining the vascularized saccules. In Pcyt1a ⌬/⌬ lungs, the numbers and lengths of apical microvilli in type II cells were reduced and few secretary vesicles or mature lamellar bodies were observed (Fig. 5C ). The lungs were collapsed, with the epithelial cells clustered tightly around nondilated alveolar saccules. Alveolar walls were thickened but were still lined with organized type I and type II cells. The integrity of the pulmonary vascular system was damaged somewhat, with capillary leakage and macrophage accumulation inside the alveolar space. Higher magnification revealed large and clearly abnormal membraneenclosed structures that appeared to arise from expansion of the Golgi complex adjacent to the nucleus (Fig. 5C ). In many type II cells, accumulation of what appeared to be lipid droplets was frequently observed, a finding that correlated with the increased triglyceride levels in Pcyt1a ⌬/⌬ lungs (Fig. 3B) . In contrast, the ultrastructure of type I alveolar cells appeared normal (data not shown). We also examined the lung ultrastructure of unborn pups just prior to birth, and similar changes were detected in type II alveolar cells from the Pcyt1a ⌬/⌬ animals (data not shown). Surfactant protein distribution. SP-B and SP-C are secreted proteins which play crucial roles in surfactant function and homeostasis. In light of the aberrant Golgi structures in the Pcyt1a ⌬/⌬ type II cells, we investigated whether the level of the unprocessed proSP-C protein, which is the cellular precursor of the mature SP-C, was altered. It was possible that the reduced level of mature SP-C that we detected in the immunoblots from the knockout lungs (Fig. 4B ) was due to inefficient processing and accumulation of the proSP-C form. In the control mice, proSP-C antibody stained perinuclear structures in the cytoplasms of all type II peripheral cells (32) . The Pcyt1a ⌬/⌬ mice showed similar subcellular localization in the type II epithelial cells (Fig. 4b, inset) , although, overall, weaker staining was observed, indicating a reduced amount of proSP-C protein (Fig. 6A) . These data suggested that the steady-state level of the precursor protein, rather than processing to the mature form during secretion from the Golgi structures, accounted for the lower amount of mature SP-C in the Pcyt1a ⌬/⌬ lungs (Fig. 4B) . Immunostaining for mature SP-B was evident in the control lungs in the cytoplasms of type II cells and lining the luminal surfaces of the peripheral saccules (Fig. 6B) . In Pcyt1a ⌬/⌬ lungs, apparent constriction of the alveolar spaces was accompanied by accumulation of aggregated SP-B-positive material inside the alveolar spaces, while the type II alveolar cells retained cytoplasmic staining. The aggregates corresponded to the elevated level of SP-B observed in the immunoblots from the knockout animals (Fig. 4B) , and these data suggested that SP-B protein synthesis and secretion into the alveolar space might be intact but that aggregation might reduce the uptake and recycling of the protein by the type II cells. The aberrant Golgi structures in the Pcyt1a ⌬/⌬ lung type II cells were apparently related to impairment of PtdCho synthesis and affected surfactant PtdCho secretion more than secretion of SP-B or the maturation of SP-C.
DISCUSSION
This work identifies CCT␣ expression as essential for lung epithelial cells to synthesize and secrete PtdCho lung surfactant, but it is not required to produce the PtdCho needed for the proliferation or differentiation program of lung epithelia. The loss of CCT␣ leads to failure of the lungs to inflate at birth, a dramatic reduction in disaturated and total PtdCho, accumulation of triglycerides, and the absence of mature lamellar bodies coupled with a significant disruption of the Golgi structures in alveolar type II cells. A large number of lung epithelial cells express type II cell differentiation marker proteins in Pcyt1a ⌬/⌬ mice. These findings are counterintuitive in light of the strict requirement for CCT␣ in cultured cells (11, 12) and the early stage lethality of Pcyt1a Ϫ/Ϫ embryos (40) . However, the normal development of the lung epithelia is ⌬/⌬ mice, palmitate destined for surfactant formation continues to be synthesized in the absence of CCT␣ and, instead of being incorporated into phospholipid, accumulates in the triglyceride pool. When CCT␣ is overexpressed in mouse lung epithelia, the animals do not produce excess surfactant PtdCho (23) , illustrating that the supply of palmitate via fatty acid synthase, rather than CCT␣, sets the upper limit for surfactant PtdCho production. The high level of CCT␣ expression in lung (17) is explained by the need to prevent other pathways from effectively competing for the pool of intracellular fatty acids produced by fatty acid synthase. CEBP/␣ is essential for lung maturation, and disaturated PtdCho and surfactant proteins are severely reduced in C/EBP␣ ⌬/⌬ knockout mice (24) . The reduction in PtdCho can be explained by the decreased expression of fatty acid synthase, since Pcyt1a was not identified as under C/EBP␣ control in the lung. Similarly, deletion of the forkhead transcription factors Foxa1 and Foxa2 results in failure of the lung epithelia to produce surfactant proteins or phospholipids (4, 38, 39) , but Pcyt1a was not identified as a target gene for these factors (39) . Keratinocyte growth factor upregulates lipogenesis in alveolar type II cells through an SREBP-1c-dependent pathway by stimulating acetyl coenzyme A carboxylase and fatty acid synthase transcription; however, Pcyt1a mRNA levels are not affected (8, 26) . Nonetheless, lung has the highest abundance of CCT␣ mRNA (40) , and the CCT␣ promoter drives high levels of transgene expression in type II lung epithelial cells (46) , suggesting that robust transcription drives CCT␣ protein accumulation. Whether transcription factors identified in cell culture systems that upregulate Pcyt1a, such as Ets-1 and Sp-1 (2, 3, 33, 34) , are involved is unknown.
Surfactant contains four major proteins, SP-A, SP-B, SP-C, and SP-D. SP-A and SP-D are relatively hydrophilic proteins that contribute to antimicrobial defense in the lung (25) . SP-C and SP-B are hydrophobic proteins that enhance the surfaceactive properties of the surfactant phospholipids (42) . SP-B is the only one of the four required for lung function and postnatal survival (6, 10, 13, 22) . Like the Pcyt1a ⌬/⌬ mice, SP-B Ϫ/Ϫ mice lack mature lamellar bodies, although PtdCho accumulation continues (10) . The SP-B Ϫ/Ϫ mice have numerous small electron-dense vesicles that are thought to harbor disaturated PtdCho (10) , in contrast to the distorted Golgi structures observed in our Pcyt1a ⌬/⌬ mice. The transcription and content of the other surfactant proteins persist in SP-B Ϫ/Ϫ mice (10, 35) , and although the steady-state mRNA levels of the four surfactant proteins is maintained in Pcyt1a ⌬/⌬ mice, the accumulation of all of these proteins, except for SP-B, was reduced in Pcyt1a ⌬/⌬ mice. These data indicate that the stability of SP-A, SP-C, and SP-D proteins may be coupled to the formation of lamellar bodies and progression through the secretory pathway.
In summary, Pcyt1a plays an essential role in phospholipid synthesis, which is required for postnatal adaptation to air breathing. Deletion of Pcyt1a in epithelial cells of the developing mouse lung caused neonatal respiratory failure with characteristics of respiratory distress syndrome in preterm human infants. Thus, we provide a useful mouse model for future studies of surfactant lipid deficiency in newborns, a common developmental defect in humans.
